Shares of Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $45.00.
Several analysts recently weighed in on the stock. TD Cowen boosted their price objective on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Weiss Ratings upgraded shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 1st. Needham & Company LLC boosted their target price on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a report on Friday, May 8th. Truist Financial boosted their target price on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Finally, Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th.
Check Out Our Latest Research Report on Astrana Health
Hedge Funds Weigh In On Astrana Health
Astrana Health Stock Up 1.2%
NASDAQ ASTH opened at $45.03 on Tuesday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. Astrana Health has a 1-year low of $18.08 and a 1-year high of $45.08. The company has a 50 day moving average of $37.75 and a 200-day moving average of $28.96. The company has a market cap of $2.51 billion, a price-to-earnings ratio of 73.82 and a beta of 1.00.
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company had revenue of $965.10 million for the quarter, compared to analysts’ expectations of $949.21 million. During the same quarter in the previous year, the firm posted $0.42 earnings per share. Astrana Health’s revenue for the quarter was up 55.6% on a year-over-year basis. On average, equities research analysts expect that Astrana Health will post 1.25 earnings per share for the current fiscal year.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Featured Stories
- Five stocks we like better than Astrana Health
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
